HRT Financial’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-6,400
Closed -$344K – 2701
2022
Q3
$344K Buy
+6,400
New +$329K ﹤0.01% 1902
2022
Q2
– Sell
-3,100
Closed -$205K – 3198
2022
Q1
$205K Sell
3,100
-2,700
-47% -$185K ﹤0.01% 2476
2021
Q4
$580K Buy
+5,800
New +$600K ﹤0.01% 1643
2021
Q2
– Sell
-1,500
Closed -$228K – 3082
2021
Q1
$228K Buy
+1,500
New +$227K ﹤0.01% 2252

Other funds holding GH

HRT Financial's GH Position: Q2 2026 in Review

HRT Financial opened a new position in Guardant Health (GH) in Q2 2026: 703,915 shares worth $106M. The stake represents 0.19% of the portfolio and ranks #84 among its holdings. This is a return to the name: HRT Financial previously reported a position in GH as recently as Q4 2025.

HRT Financial first reported a position in GH in Q4 2020 and has held it in 13 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • HRT Financial held 703,915 shares of Guardant Health worth $106M as of Q2 2026.
  • Guardant Health was a new HRT Financial position in Q2 2026.
  • Guardant Health made up 0.19% of HRT Financial's portfolio in Q2 2026, its #84 holding.
  • HRT Financial first reported a position in Guardant Health in Q4 2020 and has held it in 13 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.